Thermo Fisher to Acquire Solventum’s Purification Business for USD 4.1B
Thermo Fisher Scientific (NYSE: TMO) has agreed to acquire Solventum’s (NYSE: SOLV) Purification & Filtration...
J&J’s Tremfya Wins NMPA Approval for Crohn’s Disease Treatment
Johnson & Johnson (J&J, NYSE: JNJ) announced that its Tremfya (guselkumab) has received marketing approval...
Sanofi’s Sarclisa Wins New Japan Approval for Multiple Myeloma Combination Therapy
Sanofi (EPA: SAN, NASDAQ: SNY) announced that Japan’s Ministry of Health, Labour and Welfare (MHLW)...
YolTech Therapeutics’ YOLT-203 Shows Promise in Primary Hyperoxaluria Type 1 Trial
YolTech Therapeutics, a Shanghai-based startup specializing in lipid nanoparticle delivery and gene editing, announced positive...
HQ Pharma and Shanghai Pharmaceuticals Expand Collaboration for Global Market Access
China’s HQ Pharma (Shanghai) Co., Ltd has entered into a new collaboration agreement with Shanghai...
Green Valley and Vazyme Team Up on Alzheimer’s Disease Initiatives
China-based Green Valley (Shanghai) Pharmaceuticals Co., Ltd. and Vazyme Biotech Co., Ltd (SHA: 688105) have...
Merck’s Keytruda sBLA for LA-HNSCC Accepted by FDA for Review
Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) announced that the US Food and Drug...
CARsgen Therapeutics and Zhuhai SB Xinchuang Invest in UCARsgen for Allogeneic CAR-T Therapies
China-based CARsgen Therapeutics Holdings Ltd (HKG: 2171) has entered into an agreement with an investment...
Eli Lilly Launches New Zepbound Doses with Lower Prices for Self-Pay Patients
Eli Lilly & Co. (NYSE: LLY) announced the launch of 7.5 mg and 10 mg...
Suzhou Ribo Life Science’s RBD2080 siRNA Drug Receives Australian Clinical Trial Approval
China-based Suzhou Ribo Life Science Co., Ltd announced that its siRNA drug RBD2080 has received...
MicuRx Pharmaceuticals Sues Medpace Over Breach of Contract in Phase III Study
Sino-US biotech firm MicuRx Pharmaceuticals Inc. (SHA: 688373) has filed a lawsuit against US-based Medpace,...
Eli Lilly Acquires Organovo’s FXR Program for Inflammatory Bowel Disease
US-based Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical-stage biotech focused on inflammatory bowel disease (IBD),...
Acotec Scientific’s Vericor Catheter Wins NMPA Approval for Peripheral Vascular Surgery
China-based Acotec Scientific Holdings Ltd (HKG: 6669) announced that its peripheral disposable support catheter Vericor...
CANbridge Pharmaceuticals Doses First Patient in CAN108 Biliary Atresia Study
China-based rare disease specialist CANbridge Pharmaceuticals Inc. (HKG: 1228) announced that the first patient has...
Sandoz Launches Pyzchiva Biosimilar of J&J’s Stelara in US
Switzerland-based Sandoz (SWX: SDZ) announced the launch of Pyzchiva, a biosimilar version of Johnson &...
CDE Includes Chiral Tech’s Cerdelga Generic in Rare Disease Care Plan
China’s Center for Drug Evaluation (CDE) announced the inclusion of Beijing Chiral Tech’s generic version...
Medtronic’s BrainSense Adaptive DBS Wins FDA Approval for Parkinson’s Treatment
US-Irish medical device giant Medtronic (NYSE: MDT) announced that the US Food and Drug Administration...
SMPA Suspends Indobufen Procurement After Patent Infringement Verdict
Shanghai’s Sunshine Medical Procurement All-In-One (SMPA) announced the suspension of procurement for indobufen, manufactured by...
Xellsmart’s iPSC Therapy XS-228 Receives FDA Approval for ALS Study
Suzhou-based stem-cell startup Xellsmart announced that the U.S. FDA has approved its regulatory study of...
Huadong Medicine’s HDM1005 Receives NMPA Approval for OSA Treatment
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that its HDM1005, a long-acting GLP-1/GIP receptor...